NPI registry status
Active
2026 NPPES data Clinical & Laboratory Immunology (Allergy & Immunology) Physician NPI 1295734564 M.D.
Verify on CMS → Michael Ciliberti, M.D.
Clinical & Laboratory Immunology (Allergy & Immunology) Physician in Allentown, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 97 in Clinical & Laboratory Immunology (Allergy & Immunology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 236 beneficiaries · Clinical & Laboratory Immunology (Allergy & Immunology) Physician avg: 773
Generic prescribing
57%
generic claims · 43% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$2.9K
117 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Michael Ciliberti, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 1,409 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 1K
- Part D claims, 2024
- 57%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Michael Ciliberti, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1295734564), first enumerated 07/19/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,409 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$2.9K in reported industry payments (117 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Pennsylvania statewide board action statistics are published annually — these figures describe aggregate state activity, not Michael Ciliberti, M.D.'s individual license status. Verify directly with the state medical board.
Source: PA-BOM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1295734564 · Clinical & Laboratory Immunology (Allergy & Immunology) Physician
NPI-10 · ENUM-LEGACY · TAX-TRACE · MIPS-NEUTRAL · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1295734564
- ENUM-LEGACY 2005
- TAX-TRACE 97
- MIPS-NEUTRAL 75/100
- RX-MID 1,409
- BOOK-THIN 8 in Pennsylvania
- PHOTO-ENUM Raffaela Russo · 2005
Michael Ciliberti, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
1,409 ≥ 80th percentile 80% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Michael Ciliberti, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Michael Ciliberti, M.D.?
CMS neutral score, not measuredPrimary specialty
Clinical & Laboratory Immunology (Allergy & Immunology) Physician
Medicare Part D claims
1,409 82% vs specialty avg
MIPS final score
75/100
Specialty distribution in Pennsylvania
How Clinical & Laboratory Immunology (Allergy & Immunology) Physician compares to other specialties among Pennsylvania providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1295734564 |
|---|---|
| Specialty | Clinical & Laboratory Immunology (Allergy & Immunology) Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/19/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Michael Ciliberti, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$2.9K
Largest payer
GENZYME CORPORATION
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Michael Ciliberti, M.D.. To verify Michael Ciliberti, M.D.'s current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Michael Ciliberti, M.D. - brand share 43.0%
Clinical & Laboratory Immunology (Allergy & Immunology) Physician average
43% brand-name claims vs 57% generic, on 1,409 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,409
Total Claims
$452K
Total Drug Cost
236
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,252.6
- Total Day Supply
- 63,170
- Brand vs Generic
- 43% brand / 57% generic
- Brand Drug Cost
- $414K
- Generic Drug Cost
- $37K
- Antibiotic Claims
- 25
Patient Demographics
- Average Patient Age
- 74.2 years
- Avg HCC Risk Score
- 1.09
- Gender Split
- 66% female / 34% male
- Age Distribution
- <65: 16, 65-74: 95, 75-84: 103, 85+: 22
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Michael Ciliberti, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Montelukast Sodium
Montelukast Sodium
260 claims
- Fluticasone-Salmet… 96
Fluticasone-Salmeterol
96 claims
- Albuterol Sulfate … 88
Albuterol Sulfate Hfa
88 claims
- Fluticasone Propio… 75
Fluticasone Propionate
75 claims
- Prednisone 69
Prednisone
69 claims
- Breo Ellipta 68
Breo Ellipta
68 claims
- Epinephrine 58
Epinephrine
58 claims
- Ipratropium Bromide 48
Ipratropium Bromide
48 claims
| Drug | Claims |
|---|---|
| Montelukast Sodium | 260 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 96 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 88 |
| Fluticasone Propionate | 75 |
| Prednisone | 69 |
| Breo Ellipta Fluticasone/Vilanterol | 68 |
| Epinephrine | 58 |
| Ipratropium Bromide | 48 |
| Arnuity Ellipta Fluticasone Furoate | 47 |
| Ventolin Hfa Albuterol Sulfate | 45 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Clinical & Laboratory Immunology (Allergy & Immunology) Physician in PA →
All providers in Pennsylvania →
Compare specialties →
Clinical & Laboratory Immunology (Allergy & Immunology) Physician Overview
How Michael Ciliberti, M.D. fits within the Clinical & Laboratory Immunology (Allergy & Immunology) Physician landscape nationally.
97
Clinical & Laboratory Immunology (Allergy & Immunology) Physician Providers in US
29
States with Clinical & Laboratory Immunology (Allergy & Immunology) Physician
773
Avg Claims per Provider
Michael Ciliberti, M.D.'s 1,409 claims are above the specialty average of 773.
Nationwide Clinical & Laboratory Immunology (Allergy & Immunology) Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Ciliberti, both outside Pennsylvania so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Clinical & Laboratory Immunology (Allergy & Immunology) Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Ciliberti.
One of 8 Clinical & Laboratory Immunology (Allergy & Immunology) Physician providers enrolled in Pennsylvania, 5 are shown here.
Frequently Asked Questions
What is Michael Ciliberti, M.D.'s specialty? ▼
Michael Ciliberti, M.D. specializes in Clinical & Laboratory Immunology (Allergy & Immunology) Physician and practices in Allentown, Pennsylvania. Credentials: M.D..
How much does Michael Ciliberti, M.D. prescribe under Medicare Part D? ▼
In 2024, Michael Ciliberti, M.D. wrote 1,409 Medicare Part D claims totaling $452K in drug costs for 236 beneficiaries.
What is Michael Ciliberti, M.D.'s Medicare quality score? ▼
Michael Ciliberti, M.D. has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Michael Ciliberti, M.D. located? ▼
Michael Ciliberti, M.D. is located at 250 CETRONIA RD, Allentown, PA, 18104. Phone: (610) 841-3890.
What is Michael Ciliberti, M.D.'s NPI number? ▼
Michael Ciliberti, M.D.'s National Provider Identifier (NPI) is 1295734564, issued on 07/19/2005.
Does Michael Ciliberti, M.D. prescribe more brand-name or generic drugs? ▼
Michael Ciliberti, M.D.'s prescribing is 43% brand-name and 57% generic drugs by claim count, with $414K in brand drug costs.
How many Clinical & Laboratory Immunology (Allergy & Immunology) Physician providers are there in the US? ▼
There are 97 Clinical & Laboratory Immunology (Allergy & Immunology) Physician providers across 29 states in the US. The average Clinical & Laboratory Immunology (Allergy & Immunology) Physician provider writes 773 Medicare Part D claims per year.
What drugs does Michael Ciliberti, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Michael Ciliberti, M.D.'s most frequently prescribed drugs include Montelukast Sodium, Fluticasone-Salmeterol, Albuterol Sulfate Hfa. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Michael Ciliberti, M.D. accept Medicare? ▼
Michael Ciliberti, M.D. appears in CMS Medicare data with 1,409 Part D claims and 236 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Michael Ciliberti, M.D.'s credentials? ▼
Michael Ciliberti, M.D.'s NPI is 1295734564 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.